Drug Shortage Report for CLADRIBINE INJECTION

Last updated on 2024-04-06 History
Report ID 212507
Drug Identification Number 02319918
Brand name CLADRIBINE INJECTION
Common or Proper name CLADRIBINE INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CLADRIBINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-01-01
Actual start date 2024-01-01
Estimated end date 2024-04-14
Actual end date 2024-04-05
Shortage status Resolved
Updated date 2024-04-06
Company comments Due to production delays, we will be facing a supply interruption effective January 1, 2024 until April 14, 2024.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-04-06 English Compare
v9 2024-04-05 French Compare
v8 2024-04-05 English Compare
v7 2024-03-08 French Compare
v6 2024-03-08 English Compare
v5 2024-01-31 French Compare
v4 2024-01-31 English Compare
v3 2024-01-02 English Compare
v2 2023-12-05 French Compare
v1 2023-12-05 English Compare

Showing 1 to 10 of 10